Press release
Oncolytic Virus Therapy Market Trends, Size, Forecast - 2018-2023
Oncolytic Virus Therapy Market
Request a free sample of our report on Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market
Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.
A full report of Oncolytic Virus Therapy Market is available at: https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market
Global oncolytic virus therapy market is segregated on the basis of the geographical regions that are contributing significantly towards the growth of the market. On the basis of the geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the dominant market in the oncolytic virus immunotherapy market, globally. R&D in oncolytic virus therapy and cohesive government policies will boost innovative cancer therapies. Europe followed by APAC region are considered to be lucrative regions for the growth of oncolytic virus market owing to larger patient base and adoption for novel immunotherapies.
Major global oncolytic virus therapy market players such as Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics and so on are contributing significantly into the market growth. Various corporate strategies such as investment in R&D are contributing into the market growth of oncolytic virus therapy market. For instance, Merck announced to invest $394 million for Viralytics, recently in February 2018, which is a company based in Australia for the development of oncolytic viruses to further boost the cancer immunotherapy pembrolizumab (Keytruda).
Global Market Segmentation
By Product
• HSV-Based Oncolytic Viruses
• Adenoviruses-Based Oncolytic Viruses
• Vaccinia Virus-Based Oncolytic Viruses
• Vesicular Stomatitis Virus-Based Oncolytic Viruses
• Newcastle Disease Virus-Based Oncolytic Viruses
By Application
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others
Regional Analysis
North American
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• ROE
Asia Pacific
• India
• China
• Japan
• ROAPAC
• Rest of the World
Company Profiles
• Amgen
• BioVex Inc.,
• Cold Genesys, Inc.
• Crusade Laboratories
• Cynvec LLC
• Genelux Corp.
• JennerRex Co. Ltd
• Lokon Pharma AB
• MediGene AG
• Merck
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Therapy Market Trends, Size, Forecast - 2018-2023 here
News-ID: 2081604 • Views: …
More Releases from Orion Market Research Pvt Ltd
Insulated Tools Market 2023 Driving Factors Forecast Research 2029
The global insulated tools market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. One of the core factors that is fueling the market is the growing applications of electricity, and batteries in products such as toys, vehicles, homes, commercial, and others which has increased the demand for insulated tools across the globe. As per the annual report of Havells 2021, the company launched 12…
Canada Bio Succinic Acid Market Size, Share, Analysis, Industry Report and Forec …
The Canada bio succinic acid market is estimated to grow at a significant growth rate of 18.0% over the forecast period from $55.0 million in 2018. Canada is another major economy in North America and is the 2nd largest economy in the region. Due to the growing chemical, pharmaceutical, polybutylene succinate (PBS) and food packaging industry, demand for bio-succinic acid and other plastics has increased Canada’s share substantially. Bio-succinic acid…
Global Intelligent Airways Transportation System Market Size, Share, Analysis, I …
The global intelligent airways transportation system market is anticipated to grow at a significant CAGR during the forecast period. The Intelligent Airways Transportation System (IATS) enables airlines to better manage aviation operations through the use of information technology (IT). The primary purpose of Intelligent Airways Transportation System technology is to give passengers a pleasant flying experience and also ensure their safety.
Due to Covid-19, many governments instituted temporary quarantines. This had…
Global Environmental Health Safety Market Size, Share and Forecast 2021-2027
The global environmental health safety market is expected to grow at a significant CAGR during the forecast period. Environment, Health, and Safety (EHS) are used by businesses to describe laws, rules, regulations, professional programs, and workplace activities aimed at protecting employees, the public, and the environment's health and safety from workplace risks. The Environmental Health Safety department of the firm assurances that the company's work does not harm the environment…
More Releases for Oncolytic
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth?
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering…
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer.
Download Report:
https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas
The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take…
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy.
New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate…
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Oncolytic Virus Competitive Landscape Report
• DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
